The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

It is expected to improve access to PET MPI, particularly for patients who are challenging to image, such as those with a ...

Located in Switzerland’s Health Valley, the Genolier Innovation Hub is designed to bring late-stage medtech, pharma, biotech, ...

Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) and keeping ...

GE HealthCare shares are up nearly 1% after getting the green light late Friday from U.S. regulators to sell a new diagnostic imaging agent that analysts say could be a big seller for the [General Ele ...

The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

This summary provides key updates in the healthcare sector, including Kezar Life Sciences halting a lupus treatment trial, challenges in sickle cell gene therapy, Glenview Capital's improvements at ...

GE Healthcare Technologies Inc. received U.S. FDA approval for its novel radiotracer, Flyrcado (flurpiridaz F-18), for use in ...

Barclays analyst David Strauss raised his GE Aerospace price target to $230 from $200. It’s the highest target on the Street, ...

Geingos concluded her engagements on 20 September by attending the SDG Advocates Dinner, convened by the UN Deputy ...

The hospital director indicated that the new hospital accommodates around 550 beds compared to the old Flacq Hospital, which ...

A new analysis of tax benefits for nonprofit hospitals shows community contributions amid controversy over tax breaks for ...